Our mission is to accelerate the development of neurotechnology for human benefit.
Established by a generous donation from the Swiss entrepreneur and philanthropist Hansjörg Wyss, the Wyss Center (pronounced “Veese”) presents a new model in translational neurotechnology research, offering competitively awarded support for projects that have the potential to make substantial clinical impact.
Through its resident experts, technology platforms and funding the Wyss Center identifies and fosters creative new technology-linked solutions to treat nervous system disorders.
The Center creates prototype devices suitable for humans, and then supports their development from preclinical to initial human clinical trials that will lead to commercialization to allow widespread benefit.
The Center’s integrated approach provides access to the latest neuroscience and engineering facilities, as well as the clinical, regulatory and business expertise required to guide high risk, high return projects on their journey from research to product.
“The Wyss Center’s unique model provides expertise, technology and funding – people, platforms and projects – to accelerate development of neurodevices from research concept to clinical solution.
We don’t just carry good concepts over the valley of death, we accelerate them on their journey so they reach proof-of-concept in humans more quickly.”
Professor John Donoghue
Director of the Wyss Center
Wyss Center projects
The Center supports innovative neurotechnology projects from anywhere in the world that fit the core mission to accelerate the development of neurotechnology for human benefit and can make full use of the Center’s capabilities and resources.
A major goal is to ensure that innovative neurotechnologies advance until they are sufficiently mature to attract industry partnerships, venture funding, or other mechanisms necessary to make them broadly available to society.
Wyss Center Neurotechnology Experts
The Wyss Center includes a unique interdisciplinary team of experts who are key members of all supported research projects.
This experienced multidisciplinary neurotechnology development team from industry and academia provides the integrated scientific, engineering, clinical, regulatory and business expertise required to guide high risk, high reward projects on their journey from research to product.
The Wyss Center is based at Campus Biotech, a new research and technology center of excellence in Geneva. In May 2013 Hansjörg Wyss, the Bertarelli family, École Polytechnique Fédérale de Lausanne (EPFL), Hôpitaux Universitaires de Genève (HUG) and the University of Geneva announced their intention to launch Campus Biotech in the modern complex created by the Serono biotechnology company.
The campus provides a unique collaborative environment for faculty, students, scientists and engineers in advanced research facilities for basic, translational and human clinical research, as well as space for startups and industrial partnerships.
This new community offers an interdisciplinary approach to scientific research and collaboration that positions the Lake Geneva region at the forefront of global neuroscience research and neurotechnology development.
Other Wyss organizations
The Wyss Center in Geneva focuses on neurotechnology for human applications while other Wyss funded organizations, including the Wyss Translational Center Zurich and the Wyss Institute for Biologically Inspired Engineering, each pursue independent missions united by Hansjörg Wyss’ vision to have a beneficial impact on the world